GB202012722D0 - Validation method - Google Patents

Validation method

Info

Publication number
GB202012722D0
GB202012722D0 GBGB2012722.1A GB202012722A GB202012722D0 GB 202012722 D0 GB202012722 D0 GB 202012722D0 GB 202012722 A GB202012722 A GB 202012722A GB 202012722 D0 GB202012722 D0 GB 202012722D0
Authority
GB
United Kingdom
Prior art keywords
validation method
validation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2012722.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abcam PLC
Original Assignee
Abcam PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abcam PLC filed Critical Abcam PLC
Priority to GBGB2012722.1A priority Critical patent/GB202012722D0/en
Publication of GB202012722D0 publication Critical patent/GB202012722D0/en
Priority to PCT/GB2021/051724 priority patent/WO2022008905A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
GBGB2012722.1A 2020-07-07 2020-08-14 Validation method Ceased GB202012722D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2012722.1A GB202012722D0 (en) 2020-08-14 2020-08-14 Validation method
PCT/GB2021/051724 WO2022008905A1 (en) 2020-07-07 2021-07-07 Method of validating the selectivity of antibodies for post translational modifications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2012722.1A GB202012722D0 (en) 2020-08-14 2020-08-14 Validation method

Publications (1)

Publication Number Publication Date
GB202012722D0 true GB202012722D0 (en) 2020-09-30

Family

ID=72615342

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2012722.1A Ceased GB202012722D0 (en) 2020-07-07 2020-08-14 Validation method

Country Status (2)

Country Link
GB (1) GB202012722D0 (en)
WO (1) WO2022008905A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441140B1 (en) * 1998-09-04 2002-08-27 Cell Signaling Technology, Inc. Production of motif-specific and context-independent antibodies using peptide libraries as antigens
US8062887B2 (en) * 2005-04-01 2011-11-22 National University Corporation, Hokkaido University Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
WO2014152660A1 (en) * 2013-03-15 2014-09-25 The Regents Of The University Of California Engineered antibody scaffolds
WO2014145441A1 (en) * 2013-03-15 2014-09-18 The Trustees Of The University Of Pennsylvania Sortase-mediated protein purification and ligation
CN111201239A (en) * 2017-08-04 2020-05-26 艾博抗公开有限公司 Methods and compositions for developing antibodies specific for epitope post-translational modification states

Also Published As

Publication number Publication date
WO2022008905A1 (en) 2022-01-13

Similar Documents

Publication Publication Date Title
GB202010104D0 (en) Method
GB202004944D0 (en) Method
GB202100827D0 (en) Method
GB202007044D0 (en) Method
GB202006815D0 (en) Method
GB202004863D0 (en) Method
GB202017861D0 (en) Method
GB202015993D0 (en) Method
GB202014709D0 (en) Method
GB202014432D0 (en) Method
GB202011823D0 (en) Method
GB202010922D0 (en) Method
GB202010046D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
GB202012722D0 (en) Validation method
GB202115325D0 (en) Method
GB202100365D0 (en) Method
GB202020183D0 (en) Method
GB202020180D0 (en) Method
GB202018514D0 (en) Method
GB202018262D0 (en) Method
GB202018125D0 (en) Method
GB202017725D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)